Document Detail


Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
MedLine Citation:
PMID:  17569592     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hereditary Hemochromatosis (HH) is a genetic disorder of iron metabolism, resulting in excessive iron overload. Currently, phlebotomy is the standard effective treatment that prevents progression of tissue damage. Aim of the therapy is to reach ferritin levels between 20 and 50mugl(-1). In patients with total iron stores of more than 30g, intensive treatment by means of weekly phlebotomies during 2-3 years is required to reach this aim. More recently mechanical removal of erythrocytes through therapeutic erythrocytapheresis (TE) has become a new therapeutic modality. By means of TE, up to 1000ml erythrocytes per session can be removed, depending on patient characteristics, compared to 250ml erythrocytes per phlebotomy. Thus, TE potentially offers a more efficient method of removing iron overload with less procedures in a shorter treatment period. In a pilot study between 2002 and 2005, results from a group of HH patients treated with TE (N=6) were compared to the results of a historical control group of HH patients (N=6) treated with phlebotomy. The results showed a reduction of almost 70% in both the total number and the duration of treatments in the TE group. Although, the procedure costs compared on the basis of a single TE session were higher, the total costs for the whole treatment were comparable or cheaper with the use of TE. Future prospective studies are needed to compare both therapies in a randomized setting.
Authors:
Eva Rombout-Sestrienkova; Paulus A H van Noord; Cees Th B M van Deursen; Bob J P H Sybesma; Ans E L Nillesen-Meertens; Ger H Koek
Publication Detail:
Type:  Journal Article     Date:  2007-06-13
Journal Detail:
Title:  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis     Volume:  36     ISSN:  1473-0502     ISO Abbreviation:  Transfus. Apher. Sci.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-07-30     Completed Date:  2010-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101095653     Medline TA:  Transfus Apher Sci     Country:  England    
Other Details:
Languages:  eng     Pagination:  261-7     Citation Subset:  T    
Affiliation:
Sanquin Blood Bank Southeast Region, Geatano Martinolaan 95, 6229 GS Maastricht, The Netherlands. e.rombout@sanquin.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Component Removal*
Erythrocyte Transfusion*
Female
Hemochromatosis / therapy*
Humans
Iron Overload / therapy
Male
Middle Aged
Phlebotomy*
Pilot Projects
Retrospective Studies
Therapeutics / economics,  standards
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overnight refrigerator storage of autologous peripheral progenitor stem cells without cryopreservati...
Next Document:  Comparison of blood component preparation methods from whole blood bags based on buffy coat extracti...